404 related articles for article (PubMed ID: 19158353)
1. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.
Coughlan MT; Thorburn DR; Penfold SA; Laskowski A; Harcourt BE; Sourris KC; Tan AL; Fukami K; Thallas-Bonke V; Nawroth PP; Brownlee M; Bierhaus A; Cooper ME; Forbes JM
J Am Soc Nephrol; 2009 Apr; 20(4):742-52. PubMed ID: 19158353
[TBL] [Abstract][Full Text] [Related]
2. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
Tan AL; Sourris KC; Harcourt BE; Thallas-Bonke V; Penfold S; Andrikopoulos S; Thomas MC; O'Brien RC; Bierhaus A; Cooper ME; Forbes JM; Coughlan MT
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
4. Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes.
Brodeur MR; Bouvet C; Bouchard S; Moreau S; Leblond J; Deblois D; Moreau P
PLoS One; 2014; 9(1):e85922. PubMed ID: 24465790
[TBL] [Abstract][Full Text] [Related]
5. Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.
Sourris KC; Morley AL; Koitka A; Samuel P; Coughlan MT; Penfold SA; Thomas MC; Bierhaus A; Nawroth PP; Yamamoto H; Allen TJ; Walther T; Hussain T; Cooper ME; Forbes JM
Diabetologia; 2010 Nov; 53(11):2442-51. PubMed ID: 20631980
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products receptor RAGE controls myocardial dysfunction and oxidative stress in high-fat fed mice by sustaining mitochondrial dynamics and autophagy-lysosome pathway.
Yu Y; Wang L; Delguste F; Durand A; Guilbaud A; Rousselin C; Schmidt AM; Tessier F; Boulanger E; Neviere R
Free Radic Biol Med; 2017 Nov; 112():397-410. PubMed ID: 28826719
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?
Coughlan MT; Thallas-Bonke V; Pete J; Long DM; Gasser A; Tong DC; Arnstein M; Thorpe SR; Cooper ME; Forbes JM
Endocrinology; 2007 Feb; 148(2):886-95. PubMed ID: 17110423
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
9. Extracellular superoxide released from mitochondria mediates mast cell death by advanced glycation end products.
Yoshimaru T; Suzuki Y; Inoue T; Nishida S; Ra C
Biochim Biophys Acta; 2008 Dec; 1783(12):2332-43. PubMed ID: 18822320
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial superoxide and coenzyme Q in insulin-deficient rats: increased electron leak.
Herlein JA; Fink BD; Henry DM; Yorek MA; Teesch LM; Sivitz WI
Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1616-24. PubMed ID: 21940403
[TBL] [Abstract][Full Text] [Related]
11. RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation.
Li Y; Liu S; Zhang Z; Xu Q; Xie F; Wang J; Ping S; Li C; Wang Z; Zhang M; Huang J; Chen D; Hu L; Li C
PLoS One; 2012; 7(4):e35016. PubMed ID: 22496883
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells.
Munusamy S; MacMillan-Crow LA
Free Radic Biol Med; 2009 Apr; 46(8):1149-57. PubMed ID: 19439219
[TBL] [Abstract][Full Text] [Related]
13. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress.
Chen J; Song M; Yu S; Gao P; Yu Y; Wang H; Huang L
Mol Cell Biochem; 2010 Feb; 335(1-2):137-46. PubMed ID: 19756958
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) activate mast cells.
Sick E; Brehin S; André P; Coupin G; Landry Y; Takeda K; Gies JP
Br J Pharmacol; 2010 Sep; 161(2):442-55. PubMed ID: 20735427
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders.
Stefano GB; Challenger S; Kream RM
Eur J Nutr; 2016 Dec; 55(8):2339-2345. PubMed ID: 27084094
[TBL] [Abstract][Full Text] [Related]
17. Naringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE/NF-κB mediated mitochondrial apoptosis.
Syed AA; Reza MI; Shafiq M; Kumariya S; Singh P; Husain A; Hanif K; Gayen JR
Life Sci; 2020 Sep; 257():118118. PubMed ID: 32702445
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of catalpol on diabetes mellitus-induced male reproductive damage via suppression of the AGEs/RAGE/Nox4 signaling pathway.
Jiao N; Chen Y; Zhu Y; Wang W; Liu M; Ding W; Lv G; Lu J; Yu B; Xu H
Life Sci; 2020 Sep; 256():116736. PubMed ID: 31398417
[TBL] [Abstract][Full Text] [Related]
19. AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways.
Qin J; Peng Z; Yuan Q; Li Q; Peng Y; Wen R; Hu Z; Liu J; Xia X; Deng H; Xiong X; Hu J; Tao L
Sci Rep; 2019 Mar; 9(1):4407. PubMed ID: 30867431
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
Maeda S; Matsui T; Ojima A; Takeuchi M; Yamagishi S
Nutr Res; 2014 Sep; 34(9):807-13. PubMed ID: 25241332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
